CAREDX, INC. (CDNA) Quick Ratio
- Quick ratio · latest quarter: Value 4.35×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 4.35× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $408.01M ÷ $93.70M ≈ 4.35× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 408.01M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 93.70M USD | Liabilities, Current |
| Cash and equivalents | 373.64M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 0.00 USD | Marketable Securities, Current |
| Customer receivables | 34.38M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 6.98M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $408.01M | $93.70M | $373.64M | $0.00 | $34.38M | $6.98M | 4.35× |
| 2026-03-31 | $231.76M | $79.15M | $77.92M | $109.25M | $44.59M | $26.40M | 2.93× |
| 2025-12-31 | $219.84M | $89.85M | $65.43M | $111.78M | $42.63M | $26.70M | 2.45× |
| 2025-09-30 | $242.06M | $99.04M | $91.44M | $102.78M | $47.84M | $28.33M | 2.44× |
| 2025-06-30 | $253.62M | $93.18M | $68.21M | $118.04M | $67.36M | $27.91M | 2.72× |
| 2025-03-31 | $302.40M | $85.28M | $88.75M | $142.17M | $71.48M | $22.93M | 3.55× |
| 2024-12-31 | $325.26M | $89.37M | $114.69M | $145.96M | $64.61M | $19.50M | 3.64× |
| 2024-09-30 | $307.48M | $81.44M | $95.40M | $145.45M | $66.63M | $19.26M | 3.78× |
| 2024-06-30 | $295.03M | $78.33M | $95.78M | $133.09M | $66.16M | $19.23M | 3.77× |
| 2024-03-31 | $276.07M | $70.21M | $93.30M | $122.62M | $60.15M | $20.13M | 3.93× |
| 2023-12-31 | $286.48M | $78.07M | $82.20M | $153.22M | $51.06M | $19.47M | 3.67× |
| 2023-09-30 | $319.88M | $72.67M | $75.98M | $192.20M | $51.69M | $17.98M | 4.40× |
| 2023-06-30 | $334.30M | $74.50M | $87.79M | $194.89M | $51.63M | $18.84M | 4.49× |
| 2023-03-31 | $345.25M | $71.83M | $74.66M | $211.28M | $59.31M | $18.02M | 4.81× |
| 2022-12-31 | $359.40M | $75.97M | $89.92M | $203.17M | $66.31M | $19.23M | 4.73× |
| 2022-09-30 | $361.70M | $70.29M | $82.96M | $208.32M | $70.42M | $18.09M | 5.15× |
| 2022-06-30 | $376.36M | $78.46M | $166.83M | $139.39M | $70.14M | $18.86M | 4.80× |
| 2022-03-31 | $384.54M | $66.92M | $171.89M | $147.33M | $65.32M | $18.21M | 5.75× |
| 2021-12-31 | $408.25M | $77.30M | $348.49M | $0.00 | $59.76M | $17.19M | 5.28× |
| 2021-09-30 | $419.46M | $69.74M | $353.08M | $10.20M | $56.18M | $18.80M | 6.01× |
| 2021-06-30 | $418.01M | $56.26M | $335.63M | $34.32M | $48.07M | $15.06M | 7.43× |
| 2021-03-31 | $417.65M | $45.73M | $309.32M | $64.96M | $43.36M | $13.72M | 9.13× |
| 2020-12-31 | $259.33M | $69.22M | $134.67M | $90.03M | $34.62M | $10.01M | 3.75× |
| 2020-09-30 | (m) | $62.42M | $213.80M | (m) | $30.61M | $9.91M | (m) |
| 2020-06-30 | (m) | $56.94M | $211.41M | (m) | $27.11M | $8.74M | (m) |
| 2020-03-31 | (m) | $28.32M | $32.19M | (m) | $22.84M | $6.95M | (m) |
| 2019-12-31 | (m) | $34.83M | $38.22M | (m) | $24.06M | $6.01M | (m) |
| 2019-09-30 | (m) | $30.97M | $40.93M | (m) | $19.17M | $5.90M | (m) |
| 2019-06-30 | (m) | $28.62M | $43.47M | (m) | $17.05M | $5.34M | (m) |
| 2019-03-31 | (m) | $16.37M | $57.43M | (m) | $12.53M | $5.18M | (m) |
| 2018-12-31 | (m) | $19.50M | $64.62M | (m) | $9.76M | $4.94M | (m) |
| 2018-09-30 | (m) | $15.82M | $26.20M | (m) | $9.64M | $4.62M | (m) |
| 2018-06-30 | (m) | $14.18M | $16.25M | (m) | $8.07M | $4.67M | (m) |
| 2018-03-31 | (m) | $13.45M | $18.70M | (m) | $6.54M | $5.01M | (m) |
| 2017-12-31 | (m) | $42.91M | $16.89M | (m) | $2.99M | $5.53M | (m) |
| 2017-09-30 | (m) | $30.96M | $5.98M | (m) | $3.27M | $6.17M | (m) |
| 2017-06-30 | (m) | $54.24M | $9.10M | (m) | $3.00M | $6.34M | (m) |
| 2017-03-31 | (m) | $53.00M | $12.19M | (m) | $3.38M | $6.05M | (m) |
| 2016-12-31 | (m) | $40.83M | $17.26M | (m) | (m) | $5.46M | (m) |
| 2016-09-30 | (m) | $39.60M | $22.27M | (m) | (m) | $7.44M | (m) |
| 2016-06-30 | (m) | $38.25M | $17.14M | (m) | (m) | $8.65M | (m) |
| 2016-03-31 | (m) | $14.23M | $23.75M | (m) | (m) | $595.00K | (m) |
| 2015-12-31 | (m) | $10.15M | $29.89M | (m) | (m) | $766.00K | (m) |
| 2015-09-30 | (m) | $10.45M | $33.95M | (m) | (m) | $814.00K | (m) |
| 2015-06-30 | (m) | $8.24M | $36.89M | (m) | (m) | $731.00K | (m) |
| 2015-03-31 | (m) | $6.28M | $38.98M | (m) | (m) | $775.00K | (m) |
| 2014-12-31 | (m) | $11.13M | $36.43M | (m) | (m) | $686.00K | (m) |
| 2014-09-30 | (m) | $11.12M | $39.05M | (m) | (m) | $496.00K | (m) |
| 2014-06-30 | (m) | $21.21M | $7.87M | (m) | (m) | $614.00K | (m) |
| 2014-03-31 | (m) | (m) | $4.84M | (m) | (m) | (m) | (m) |
| 2014-01-01 | (m) | (m) | $5.13M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $7.59M | $5.13M | (m) | (m) | $518.00K | (m) |
| 2013-09-30 | (m) | (m) | $6.09M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $4.49M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $5.83M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $2.36M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |